![Xi Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Xi Liu served as an Independent Director at I-Mab in 2021-2022.
Prior to that, Liu earned an undergraduate degree from China Agricultural University in 2006 and a doctorate from the University of Pittsburgh School of Medicine in 2011.
Former positions of Xi Liu
| Companies | Position | End |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Director/Board Member | 31/08/2022 |
Training of Xi Liu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
China Agricultural University
 China Agricultural University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Xi Liu
Choose MarketScreener 
